Literature DB >> 10485078

Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.

Y N Sun1, D C DuBois, R R Almon, N A Pyszczynski, W J Jusko.   

Abstract

Dose-dependent and repeated-dose effects of methylprednisolone (MPL) on down-regulation of glucocorticoid receptor messenger RNA (GR mRNA) and GR density, as well as tyrosine aminotransferase (TAT) mRNA and TAT induction by receptor/gene-mediated mechanisms in rat liver were examined. A previously developed pharmacokinetic/pharmacodynamic (PK/PD) model was used to design these studies which sought to challenge the model. Three groups of male adrenalectomized Wistar rats received MPL by i.v. injection: low-dose (10 mg/kg at Time 0), high-dose (50 mg/kg at Time 0), and dual-dose (50 mg/kg at Time 0 and 24 hr). Plasma concentrations of MPL, and hepatic content of free GR, GR mRNA, TAT mRNA, and TAT activity were determined. The P-Pharm program was applied for population analysis of MPL PK revealing low interindividual variation in CL and Vc values (3-14%). Two indirect response models were applied to test two competing hypotheses for GR mRNA dynamics. Indirect Pharmacodynamic Response Model I (Model A) where the complex in the nucleus decreases the transcription rate of GR mRNA better described GR mRNA/GR down-regulation. Levels of TAT mRNA began to increase at 1-2 hr, reached a maximum at 5-6 hr, and declined to the baseline at 12-14 hr after MPL dosing. The induction of TAT activity followed a similar pattern with a delay of about 1-2 hr. The low-dose group had 50-60% of the TAT mRNA and TAT induction compared to the high-dose group. Since the GR density returned to about 70% of the baseline level before the second 50 mg/kg dose at 24 hr, tolerance was found for TAT mRNA/TAT induction where only 50-60% of the initial responses were produced. Our fourth-generation model describes the dose dependence and tolerance effects of TAT mRNA/TAT induction by MPL involving multiple-step signal transduction controlled by the steroid regimen, free GR density, and GR occupancy. This model may provide the foundation for studying other induced proteins or enzymes mediated by the similar receptor/nuclear events.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10485078     DOI: 10.1023/a:1020746822634

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  50 in total

1.  Glucocorticosteroid receptor dimerization investigated by analysis of receptor binding to glucocorticosteroid responsive elements using a monomer-dimer equilibrium model.

Authors:  I Segard-Maurel; K Rajkowski; N Jibard; G Schweizer-Groyer; E E Baulieu; F Cadepond
Journal:  Biochemistry       Date:  1996-02-06       Impact factor: 3.162

2.  Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics.

Authors:  Y N Sun; W J Jusko
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

Review 3.  Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates.

Authors:  D T Boumpas; G P Chrousos; R L Wilder; T R Cupps; J E Balow
Journal:  Ann Intern Med       Date:  1993-12-15       Impact factor: 25.391

Review 4.  Homologous down regulation of the glucocorticoid receptor: the molecular machinery.

Authors:  R H Oakley; J A Cidlowski
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1993       Impact factor: 1.807

5.  Characterization of the protein-protein interactions determining the heat shock protein (hsp90.hsp70.hsp56) heterocomplex.

Authors:  M J Czar; J K Owens-Grillo; K D Dittmar; K A Hutchison; A M Zacharek; K L Leach; M R Deibel; W B Pratt
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

6.  Regulation of glucocorticoid receptor protein and mRNA levels.

Authors:  W V Vedeckis; M Ali; H R Allen
Journal:  Cancer Res       Date:  1989-04-15       Impact factor: 12.701

7.  Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes.

Authors:  L E Fisher; E A Ludwig; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

8.  Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heart failure.

Authors:  J A Bauer; H L Fung
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

9.  Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation.

Authors:  D B Haughey; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

10.  Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

Authors:  R I Scheinman; P C Cogswell; A K Lofquist; A S Baldwin
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

View more
  24 in total

1.  The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series.

Authors:  Richard R Almon; Debra C DuBois; William H Piel; William J Jusko
Journal:  Pharmacogenomics       Date:  2004-07       Impact factor: 2.533

2.  Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats.

Authors:  Anasuya Hazra; Nancy A Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2007-08-03       Impact factor: 4.200

3.  A dynamical systems analysis of the indirect response model with special emphasis on time to peak response.

Authors:  Lambertus A Peletier; Johan Gabrielsson; Jacintha den Haag
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

4.  Pharmacogenomic responses of rat liver to methylprednisolone: an approach to mining a rich microarray time series.

Authors:  Richard R Almon; Debra C Dubois; Jin Y Jin; William J Jusko
Journal:  AAPS J       Date:  2005-08-18       Impact factor: 4.009

5.  Corticosteroid-regulated genes in rat kidney: mining time series array data.

Authors:  Richard R Almon; William Lai; Debra C DuBois; William J Jusko
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-06-28       Impact factor: 4.310

6.  Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle.

Authors:  Richard R Almon; Debra C Dubois; Jin Y Jin; William J Jusko
Journal:  J Endocrinol       Date:  2005-01       Impact factor: 4.286

7.  Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; Jun Qu; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-27       Impact factor: 2.745

8.  Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.

Authors:  Vivaswath S Ayyar; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2017-07-20       Impact factor: 4.030

9.  Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens.

Authors:  Richard R Almon; Debra C DuBois; Zhenling Yao; Eric P Hoffman; Svetlana Ghimbovschi; William J Jusko
Journal:  Physiol Genomics       Date:  2007-05-01       Impact factor: 3.107

10.  Pharmacodynamic modeling of acute and chronic effects of methylprednisolone on hepatic urea cycle genes in rats.

Authors:  Anasuya Hazra; Debra C DuBois; Richard R Almon; Grayson H Snyder; William J Jusko
Journal:  Gene Regul Syst Bio       Date:  2008-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.